The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Hormone Replacement Therapy (HRT)-Global Market Insights and Sales Trends 2024

Hormone Replacement Therapy (HRT)-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1834432

No of Pages : 114

Ask Your Query

Synopsis

Hormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.

The global Hormone Replacement Therapy (HRT) market size is expected to reach US$ 20930 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Hormone Replacement Therapy (HRT) in various end use industries.

The expanding demands from the Menopause, Hypothyroidism, Growth Hormone Deficiency and Male Hypogonadism, are propelling Hormone Replacement Therapy (HRT) market. Estrogen Hormone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Growth Hormone segment is estimated at % CAGR for the next seven-year period.

Market competition is intense. Eli Lilly, Pfizer, AbbVie, Novo Nordisk, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 players combined 45.14% market share in all.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hormone Replacement Therapy (HRT), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Hormone Replacement Therapy (HRT) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Hormone Replacement Therapy (HRT) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hormone Replacement Therapy (HRT) sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Hormone Replacement Therapy (HRT) covered in this report include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck, Mylan, Bayer, Teva and Novartis, etc.

The global Hormone Replacement Therapy (HRT) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Eli Lilly
  • Pfizer
  • AbbVie
  • Novo Nordisk
  • Merck
  • Mylan
  • Bayer
  • Teva
  • Novartis
  • Abbott
  • Roche
  • Endo International
  • Ipsen
  • ANI Pharmaceuticals
  • TherapeuticsMD

Global Hormone Replacement Therapy (HRT) market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Hormone Replacement Therapy (HRT) market, Segment by Type:

  • Estrogen Hormone
  • Growth Hormone
  • Thyroid Hormone
  • Testosterone Hormone

Global Hormone Replacement Therapy (HRT) market, by Application

  • Menopause
  • Hypothyroidism
  • Growth Hormone Deficiency
  • Male Hypogonadism
  • Other Diseases

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hormone Replacement Therapy (HRT) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Hormone Replacement Therapy (HRT)
1.1 Hormone Replacement Therapy (HRT) Market Overview
1.1.1 Hormone Replacement Therapy (HRT) Product Scope
1.1.2 Hormone Replacement Therapy (HRT) Market Status and Outlook
1.2 Global Hormone Replacement Therapy (HRT) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hormone Replacement Therapy (HRT) Market Size by Region (2018-2029)
1.4 Global Hormone Replacement Therapy (HRT) Historic Market Size by Region (2018-2023)
1.5 Global Hormone Replacement Therapy (HRT) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hormone Replacement Therapy (HRT) Market Size (2018-2029)
1.6.1 North America Hormone Replacement Therapy (HRT) Market Size (2018-2029)
1.6.2 Europe Hormone Replacement Therapy (HRT) Market Size (2018-2029)
1.6.3 Asia-Pacific Hormone Replacement Therapy (HRT) Market Size (2018-2029)
1.6.4 Latin America Hormone Replacement Therapy (HRT) Market Size (2018-2029)
1.6.5 Middle East & Africa Hormone Replacement Therapy (HRT) Market Size (2018-2029)
2 Hormone Replacement Therapy (HRT) Market by Type
2.1 Introduction
2.1.1 Estrogen Hormone
2.1.2 Growth Hormone
2.1.3 Thyroid Hormone
2.1.4 Testosterone Hormone
2.2 Global Hormone Replacement Therapy (HRT) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hormone Replacement Therapy (HRT) Historic Market Size by Type (2018-2023)
2.2.2 Global Hormone Replacement Therapy (HRT) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hormone Replacement Therapy (HRT) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hormone Replacement Therapy (HRT) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hormone Replacement Therapy (HRT) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hormone Replacement Therapy (HRT) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hormone Replacement Therapy (HRT) Revenue Breakdown by Type (2018-2029)
3 Hormone Replacement Therapy (HRT) Market Overview by Application
3.1 Introduction
3.1.1 Menopause
3.1.2 Hypothyroidism
3.1.3 Growth Hormone Deficiency
3.1.4 Male Hypogonadism
3.1.5 Other Diseases
3.2 Global Hormone Replacement Therapy (HRT) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hormone Replacement Therapy (HRT) Historic Market Size by Application (2018-2023)
3.2.2 Global Hormone Replacement Therapy (HRT) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hormone Replacement Therapy (HRT) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hormone Replacement Therapy (HRT) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hormone Replacement Therapy (HRT) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hormone Replacement Therapy (HRT) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hormone Replacement Therapy (HRT) Revenue Breakdown by Application (2018-2029)
4 Hormone Replacement Therapy (HRT) Competition Analysis by Players
4.1 Global Hormone Replacement Therapy (HRT) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hormone Replacement Therapy (HRT) as of 2022)
4.3 Date of Key Players Enter into Hormone Replacement Therapy (HRT) Market
4.4 Global Top Players Hormone Replacement Therapy (HRT) Headquarters and Area Served
4.5 Key Players Hormone Replacement Therapy (HRT) Product Solution and Service
4.6 Competitive Status
4.6.1 Hormone Replacement Therapy (HRT) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly
5.1.1 Eli Lilly Profile
5.1.2 Eli Lilly Main Business
5.1.3 Eli Lilly Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.1.4 Eli Lilly Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.2.4 Pfizer Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer Recent Developments
5.3 AbbVie
5.3.1 AbbVie Profile
5.3.2 AbbVie Main Business
5.3.3 AbbVie Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.3.4 AbbVie Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.3.5 Novo Nordisk Recent Developments
5.4 Novo Nordisk
5.4.1 Novo Nordisk Profile
5.4.2 Novo Nordisk Main Business
5.4.3 Novo Nordisk Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.4.4 Novo Nordisk Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.4.5 Novo Nordisk Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.5.4 Merck Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Recent Developments
5.6 Mylan
5.6.1 Mylan Profile
5.6.2 Mylan Main Business
5.6.3 Mylan Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.6.4 Mylan Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.6.5 Mylan Recent Developments
5.7 Bayer
5.7.1 Bayer Profile
5.7.2 Bayer Main Business
5.7.3 Bayer Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.7.4 Bayer Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.7.5 Bayer Recent Developments
5.8 Teva
5.8.1 Teva Profile
5.8.2 Teva Main Business
5.8.3 Teva Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.8.4 Teva Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.8.5 Teva Recent Developments
5.9 Novartis
5.9.1 Novartis Profile
5.9.2 Novartis Main Business
5.9.3 Novartis Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.9.4 Novartis Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.9.5 Novartis Recent Developments
5.10 Abbott
5.10.1 Abbott Profile
5.10.2 Abbott Main Business
5.10.3 Abbott Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.10.4 Abbott Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.10.5 Abbott Recent Developments
5.11 Roche
5.11.1 Roche Profile
5.11.2 Roche Main Business
5.11.3 Roche Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.11.4 Roche Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.11.5 Roche Recent Developments
5.12 Endo International
5.12.1 Endo International Profile
5.12.2 Endo International Main Business
5.12.3 Endo International Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.12.4 Endo International Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.12.5 Endo International Recent Developments
5.13 Ipsen
5.13.1 Ipsen Profile
5.13.2 Ipsen Main Business
5.13.3 Ipsen Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.13.4 Ipsen Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.13.5 Ipsen Recent Developments
5.14 ANI Pharmaceuticals
5.14.1 ANI Pharmaceuticals Profile
5.14.2 ANI Pharmaceuticals Main Business
5.14.3 ANI Pharmaceuticals Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.14.4 ANI Pharmaceuticals Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.14.5 ANI Pharmaceuticals Recent Developments
5.15 TherapeuticsMD
5.15.1 TherapeuticsMD Profile
5.15.2 TherapeuticsMD Main Business
5.15.3 TherapeuticsMD Hormone Replacement Therapy (HRT) Products, Services and Solutions
5.15.4 TherapeuticsMD Hormone Replacement Therapy (HRT) Revenue (US$ Million) & (2018-2023)
5.15.5 TherapeuticsMD Recent Developments
6 North America
6.1 North America Hormone Replacement Therapy (HRT) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hormone Replacement Therapy (HRT) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hormone Replacement Therapy (HRT) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hormone Replacement Therapy (HRT) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hormone Replacement Therapy (HRT) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hormone Replacement Therapy (HRT) Market Dynamics
11.1 Hormone Replacement Therapy (HRT) Industry Trends
11.2 Hormone Replacement Therapy (HRT) Market Drivers
11.3 Hormone Replacement Therapy (HRT) Market Challenges
11.4 Hormone Replacement Therapy (HRT) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock